Pioneer Surgical Technology Expands Biomanufacturing Facility in Greenville, NC
Pioneer Surgical doubles the size of its Greenville, North Carolina biomanufacturing facility to accommodate growth of its biologics line, which includes the flagship product nanOss® Bioactive and the recently launched nanOss Bioactive 3D.
Pioneer Surgical Technology today announces the grand opening of its newly expanded Greenville manufacturing facility. The location houses the primary manufacturing operations for Pioneer Surgical’s biologic products sold in the United States and Europe.
Regarding Pioneer’s latest expansion, Mr. Shane Ray, General Manager of Biologics for Pioneer stated, “Since the creation of our biologics business unit in 2007, Pioneer has seen robust sales growth for our spine, orthopedic, and biologic products. Expanding our biomanufacturing facility to increase our capacity will assist in our aggressive future growth plans within and outside the USA. This expansion shows our commitment to the North Carolina area as well as our commitment to being a top tier provider of surgical products for bone and soft tissue procedures.” Mr. Ray’s announcement comes on the heels of the launch of Pioneer’s nanOss Bioactive 3D, the newest addition to its flagship bone graft product line, nanOss Bioactive.
Pioneer Surgical Biologics now offers a full line of synthetic bone grafts, human tissue products including machined lateral, traditional lumbar and cervical allograft, human demineralized bone matrix (DBM) bone grafts, as well as bone graft delivery accessories. For more information regarding Pioneer’s Biologics Product offerings, please visit the Pioneer Surgical website athttp://www.pioneersurgical.com.
About Pioneer Surgical Technology, Inc.
Pioneer Surgical Technology, Inc. is a dynamic medical device firm founded in 1992. Pioneer’s focus on innovation has resulted in over 130 U.S. and foreign patents, with numerous patents pending. The company has a comprehensive portfolio of orthopedic, spine and biologic systems. Pioneer entered the orthobiologics market with two acquisitions in 2007. Its Orthopedic, Spine, and Biologics divisions produce state-of-the-art, cost-effective solutions for surgical procedures that have proven difficult or problematic for both surgeons and patients. Pioneer employs more than 270 people worldwide. For more information on Pioneer and its products, visit http://www.pioneersurgical.com.